$NROM
NOBLE ROMANS INC Stock $nrom

$nrom Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000165495423006093 Filed on May 10, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$3.992M	$3.308M	$3.465M
YoY Change	6.47%	-4.54%	5.57%
Cost Of Revenue	$2.666M	$1.168M	$2.653M
YoY Change	-5.31%	-55.98%	60.05%
Gross Profit	$1.326M	$2.140M	$812.4K
YoY Change	41.99%	163.42%	-50.0%
Gross Profit Margin	33.22%	64.7%	23.45%
Selling, General & Admin	$526.3K	$518.8K	$540.5K
YoY Change	-2.49%	-4.01%	81.03%
% of Gross Profit	39.69%	24.24%	66.53%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$224.3K	$201.3K	$234.8K
YoY Change	-5.27%	-14.29%	-17.11%
% of Gross Profit	16.91%	9.4%	28.9%
Operating Expenses	$2.666M	$1.168M	$653.3K
YoY Change	-5.31%	78.74%	41.0%
Operating Profit	$704.4K	$1.526M	$159.1K
YoY Change	150.14%	858.73%	-86.3%
Interest Expense	$378.8K	$383.3K	$341.9K
YoY Change	8.93%	12.11%	2.3%
% of Operating Profit	53.78%	25.12%	214.83%
Other Income/Expense, Net
YoY Change
Pretax Income	$325.6K	$1.142M	-$182.7K
YoY Change	-592.3%	-725.19%	-122.09%
Income Tax	$0.00	$274.2K	-$46.04K
% Of Pretax Income	0.0%	24.0%
Net Earnings	$325.6K	$868.3K	-$136.7K
YoY Change	-747.77%	-735.18%	-116.52%
Net Earnings / Revenue	8.15%	26.25%	-3.94%
Basic Earnings Per Share	$0.02	$0.04	-$0.01
Diluted Earnings Per Share	$0.01	$0.04	-$0.01
COMMON SHARES
Basic Shares Outstanding	22.22M shares	22.22M shares	22.22M shares
Diluted Shares Outstanding	23.50M shares	23.63M shares	23.47M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$686.0K	$463.3K	$808.0K
YoY Change	-23.8%	-42.66%	-56.85%
Cash & Equivalents	$686.0K	$463.3K	$808.0K
Short-Term Investments
Other Short-Term Assets	$410.7K	$401.4K	$441.6K
YoY Change	-8.85%	-9.11%	-7.6%
Inventory	$1.005M	$1.007M	$1.000M
Prepaid Expenses	$410.7K	$401.4K
Receivables	$389.6K	$377.6K	$886.4K
Other Receivables	$1.460M	$1.460M	$0.00
Total Short-Term Assets	$4.368M	$4.183M	$3.136M
YoY Change	29.32%	33.37%	-26.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.552M	$4.631M	$11.33M
YoY Change	-10.82%	-59.12%	9.32%
Goodwill	$278.5K	$278.5K
YoY Change	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.044M	$4.044M	$390.8K
YoY Change	914.75%	934.72%	-90.08%
Total Long-Term Assets	$14.57M	$14.82M	$16.13M
YoY Change	-8.62%	-8.14%	8.89%
TOTAL ASSETS
Total Short-Term Assets	$4.368M	$4.183M	$3.136M
Total Long-Term Assets	$14.57M	$14.82M	$16.13M
Total Assets	$18.94M	$19.00M	$19.26M
YoY Change	-1.98%	-1.38%	0.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$572.1K	$598.8K	$607.6K
YoY Change	-22.68%	-1.45%	-15.89%
Accrued Expenses	$799.2K	$799.2K	$668.8K
YoY Change	16.61%	19.49%	61.84%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.000M	$1.000M
YoY Change	499.99%
Total Short-Term Liabilities	$2.371M	$2.398M	$1.276M
YoY Change	48.96%	87.87%	12.4%
LONG-TERM LIABILITIES
Long-Term Debt	$7.766M	$7.956M	$8.611M
YoY Change	-9.28%	-7.6%	5.58%
Other Long-Term Liabilities	$5.727M	$5.903M	$6.612M
YoY Change	-11.14%	-10.72%	0.15%
Total Long-Term Liabilities	$13.49M	$13.86M	$15.22M
YoY Change	-10.08%	-8.96%	3.15%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.371M	$2.398M	$1.276M
Total Long-Term Liabilities	$13.49M	$13.86M	$15.22M
Total Liabilities	$15.86M	$16.26M	$16.50M
YoY Change	-4.41%	-1.46%	3.81%
SHAREHOLDERS EQUITY
Retained Earnings	-$21.76M	-$22.08M
YoY Change	-1.47%
Common Stock	$24.83M	$24.83M
YoY Change	0.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.073M	$2.741M	$2.765M
YoY Change
Total Liabilities & Shareholders Equity	$18.94M	$19.00M	$19.26M
YoY Change	-1.98%	-1.38%	0.95%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$325.6K	$868.3K	-$136.7K
YoY Change	-747.77%	-735.18%	-116.52%
Depreciation, Depletion And Amortization	$224.3K	$201.3K	$234.8K
YoY Change	-5.27%	-14.29%	-17.11%
Cash From Operating Activities	$538.8K	-$192.2K	$10.86K
YoY Change	257.64%	-1870.79%	-98.45%
INVESTING ACTIVITIES
Capital Expenditures	$16.09K	$13.34K	$466.4K
YoY Change	-127.58%	-97.14%	2009.85%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$16.09K	-$13.34K	-$466.4K
YoY Change	-72.42%	-97.14%	2009.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$300.0K	-$116.7K	$0.00
YoY Change
NET CHANGE
Cash From Operating Activities	$538.8K	-$192.2K	$10.86K
Cash From Investing Activities	-$16.09K	-$13.34K	-$466.4K
Cash From Financing Activities	-$300.0K	-$116.7K	$0.00
Net Change In Cash	$222.7K	-$322.2K	-$455.5K
YoY Change	141.27%	-29.26%	-167.15%
FREE CASH FLOW
Cash From Operating Activities	$538.8K	-$192.2K	$10.86K
Capital Expenditures	$16.09K	$13.34K	$466.4K
Free Cash Flow	$522.7K	-$205.6K	-$455.5K
YoY Change	150.09%	-54.87%	-167.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	nrom	Number Of Franchises Licenses In Operation NumberOfFranchisesLicensesInOperation	60000	usd
CY2022Q1	nrom	Number Of Franchises Licenses In Operation NumberOfFranchisesLicensesInOperation	83000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22215512	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2023Q1	nrom	Stock Dilution StockDilution	162500	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23628012	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22215512	shares
CY2022Q1	nrom	Diluted Earnings Per Share Net Loss DilutedEarningsPerShareNetLoss	-121071	usd
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23465512	shares
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q4	us-gaap	Assets Current AssetsCurrent	3032303	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	4183010	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	4351558	usd
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000709005
CY2023Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	4358367	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3116030	usd
CY2023Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3127880	usd
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22215512	shares
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	63097	usd
CY2023Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	57774	usd
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22215512	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22215512	shares
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	466382	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13336	usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Entity File Number EntityFileNumber	0-11104
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7530685	usd
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	NOBLE ROMAN’S, INC
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	IN
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	35-1281154
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7544021	usd
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	6612 E
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	75th Street
CY2023Q1	dei	Entity Address Address Line3 EntityAddressAddressLine3	Suite 450
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Indianapolis
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	IN
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2817477	usd
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	46250
CY2023Q1	dei	City Area Code CityAreaCode	317
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	634-3377
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2912993	usd
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	22215512	shares
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	785522	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	463283	usd
CY2022Q4	nrom	Employee Retention Tax Credit Receivable EmployeeRetentionTaxCreditReceivable	0	usd
CY2023Q1	nrom	Employee Retention Tax Credit Receivable EmployeeRetentionTaxCreditReceivable	1460444	usd
CY2022Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	824091	usd
CY2023Q1	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	851225	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	997868	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	1006689	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	424822	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	401369	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4713208	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4631028	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3374841	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3100651	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	934036	usd
CY2023Q1	us-gaap	Deferred Costs DeferredCosts	943109	usd
CY2022Q4	us-gaap	Goodwill Goodwill	278466	usd
CY2023Q1	us-gaap	Goodwill Goodwill	278466	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5660155	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5484455	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	350189	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	377611	usd
CY2022Q4	us-gaap	Assets Assets	18343198	usd
CY2023Q1	us-gaap	Assets Assets	18998330	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	650582	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	598748	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	799164	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	799164	usd
CY2022Q4	nrom	Current Portion Of Corbel Loan Payable CurrentPortionOfCorbelLoanPayable	866667	usd
CY2023Q1	nrom	Current Portion Of Corbel Loan Payable CurrentPortionOfCorbelLoanPayable	1000000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2316413	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2397912	usd
CY2022Q4	nrom	Term Loan Payable To Corbel TermLoanPayableToCorbel	7470900	usd
CY2023Q1	nrom	Term Loan Payable To Corbel TermLoanPayableToCorbel	7330892	usd
CY2022Q4	nrom	Corbel Warrant Value CorbelWarrantValue	29037	usd
CY2023Q1	nrom	Corbel Warrant Value CorbelWarrantValue	29037	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	622864	usd
CY2023Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	625000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5103286	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4931053	usd
CY2022Q4	us-gaap	Deferred Revenue And Credits Noncurrent DeferredRevenueAndCreditsNoncurrent	934036	usd
CY2023Q1	us-gaap	Deferred Revenue And Credits Noncurrent DeferredRevenueAndCreditsNoncurrent	943109	usd
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	14160123	usd
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	13859091	usd
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.00
CY2023Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.00
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22215512	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	24819736	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	24826130	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22953074	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22084803	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1866662	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2741327	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18343198	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18998330	usd
CY2022Q1	nrom	Restaurant Revenue Company Owned Craft Pizza Pub RestaurantRevenueCompanyOwnedCraftPizzaPub	2283598	usd
CY2023Q1	nrom	Restaurant Revenue Company Owned Craft Pizza Pub RestaurantRevenueCompanyOwnedCraftPizzaPub	2090342	usd
CY2022Q1	nrom	Restaurant Revenue Company Owned Non Traditional RestaurantRevenueCompanyOwnedNonTraditional	133129	usd
CY2023Q1	nrom	Restaurant Revenue Company Owned Non Traditional RestaurantRevenueCompanyOwnedNonTraditional	223381	usd
CY2022Q1	nrom	Revenue Recognition Services Franchise RevenueRecognitionServicesFranchise	1034244	usd
CY2023Q1	nrom	Revenue Recognition Services Franchise RevenueRecognitionServicesFranchise	987342	usd
CY2022Q1	us-gaap	Payment For Administrative Fees PaymentForAdministrativeFees	14215	usd
CY2023Q1	us-gaap	Payment For Administrative Fees PaymentForAdministrativeFees	6738	usd
CY2022Q1	us-gaap	Revenues Revenues	3465186	usd
CY2023Q1	us-gaap	Revenues Revenues	3307803	usd
CY2022Q1	nrom	Restaurant Expenses Company Expenses Craft Pizza Pub RestaurantExpensesCompanyExpensesCraftPizzaPub	2058529	usd
CY2023Q1	nrom	Restaurant Expenses Company Expenses Craft Pizza Pub RestaurantExpensesCompanyExpensesCraftPizzaPub	1914821	usd
CY2022Q1	nrom	Restaurant Expenses Company Owned Non Traditional RestaurantExpensesCompanyOwnedNonTraditional	132877	usd
CY2023Q1	nrom	Restaurant Expenses Company Owned Non Traditional RestaurantExpensesCompanyOwnedNonTraditional	121830	usd
CY2022Q1	nrom	Franchising Expenses Benefit FranchisingExpensesBenefit	461355	usd
CY2023Q1	nrom	Franchising Expenses Benefit FranchisingExpensesBenefit	-868946	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	2652761	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1167705	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	112753	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	95517	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	540530	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	518832	usd
CY2022Q1	nrom	Non Operating Expenses NonOperatingExpenses	3306044	usd
CY2023Q1	nrom	Non Operating Expenses NonOperatingExpenses	1782054	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	159142	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-46041	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	274190	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1525749	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	341879	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	383289	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-182737	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	1142460	usd
CY2023Q1	nrom	Net Benefit Or Refund NetBenefitOrRefund	1460000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-136696	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	868270	usd
CY2022Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	22215512	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	22215512	shares
CY2022Q1	nrom	Weighted Average Number Of Common Shares Outstanding Diluted WeightedAverageNumberOfCommonSharesOutstandingDiluted	23465512	shares
CY2023Q1	nrom	Weighted Average Number Of Common Shares Outstanding Diluted WeightedAverageNumberOfCommonSharesOutstandingDiluted	23628012	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1866662	usd
CY2023Q1	nrom	Amortization Of Value Of Employee Stock Options AmortizationOfValueOfEmployeeStockOptions	6395	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	868270	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2741327	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2894564	usd
CY2022Q1	nrom	Amortization Of Value Of Employee Stock Options AmortizationOfValueOfEmployeeStockOptions	7623	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-136696	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	2765491	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-136696	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	868270	usd
CY2022Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	234811	usd
CY2023Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	201252	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	6099	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	25253	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-46041	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	274190	usd
CY2023Q1	nrom	Employee Retention Tax Credit EmployeeRetentionTaxCredit	-1460444	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	18096	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-27134	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-6363	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-8821	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-26305	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	23453	usd
CY2022Q1	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	-66407	usd
CY2023Q1	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	-27422	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	33662	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-60834	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	10856	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-192237	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-466382	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13336	usd
CY2022Q1	nrom	Employee Retention Tax Credit EmployeeRetentionTaxCredit	0	usd
CY2023Q1	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	116667	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-116667	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-455526	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-322240	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1263513	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	785523	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	807987	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	463283	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	227099	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	271160	usd
CY2023Q1	us-gaap	Line Of Credit Facility Maximum Amount Outstanding During Period LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod	5000	usd
CY2023Q1	us-gaap	Line Of Credit Facility Description LineOfCreditFacilityDescription	the Tax Payer Certainty and Disaster Relief Act (“Relief Act”) (Division EE of the Consolidated Appropriations Act). The Relief Act modified the credit to be 70% of up to $10,000 of qualified wages per quarter in 2021 through June 30, 2021.
CY2023Q1	nrom	Government Grant GovernmentGrant	1718000	usd
CY2023Q1	nrom	Expenses Deducted ExpensesDeducted	258000	usd
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q1	nrom	Deferred Contract Income And Deferred Costs DeferredContractIncomeAndDeferredCosts	934000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	868270	usd
CY2023Q1	nrom	Diluted Earnings Per Share Net Loss DilutedEarningsPerShareNetLoss	883895	usd
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-136696	usd
CY2023Q1	nrom	Employee Retention Tax Credit Amount EmployeeRetentionTaxCreditAmount	1718000	usd
CY2023Q1	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	1718000	usd
CY2023Q1	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	258000	usd
CY2023Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1460000	usd
CY2023Q1	nrom	Employee Credit EmployeeCredit	5000	usd
CY2023Q1	us-gaap	Salaries And Wages SalariesAndWages	10000	usd

Files In Submission

Name	View Source	Status
nrom-20230331_def.xml	Edgar Link	unprocessable
0001654954-23-006093-index-headers.html	Edgar Link	pending
0001654954-23-006093-index.html	Edgar Link	pending
0001654954-23-006093.txt	Edgar Link	pending
0001654954-23-006093-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nrom-20230331.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nrom_10q.htm	Edgar Link	pending
nrom_ex107.htm	Edgar Link	pending
nrom_ex107img1.jpg	Edgar Link	pending
nrom_ex107img10.jpg	Edgar Link	pending
nrom_ex107img100.jpg	Edgar Link	pending
nrom_ex107img101.jpg	Edgar Link	pending
nrom_ex107img102.jpg	Edgar Link	pending
nrom_ex107img103.jpg	Edgar Link	pending
nrom_ex107img104.jpg	Edgar Link	pending
nrom_ex107img105.jpg	Edgar Link	pending
nrom_ex107img106.jpg	Edgar Link	pending
nrom_ex107img107.jpg	Edgar Link	pending
nrom_ex107img108.jpg	Edgar Link	pending
nrom_ex107img109.jpg	Edgar Link	pending
nrom_ex107img11.jpg	Edgar Link	pending
nrom_ex107img110.jpg	Edgar Link	pending
nrom_ex107img111.jpg	Edgar Link	pending
nrom_ex107img112.jpg	Edgar Link	pending
nrom_ex107img113.jpg	Edgar Link	pending
nrom_ex107img114.jpg	Edgar Link	pending
nrom_ex107img115.jpg	Edgar Link	pending
nrom_ex107img116.jpg	Edgar Link	pending
nrom_ex107img117.jpg	Edgar Link	pending
nrom_ex107img118.jpg	Edgar Link	pending
nrom_ex107img119.jpg	Edgar Link	pending
nrom_ex107img12.jpg	Edgar Link	pending
nrom_ex107img120.jpg	Edgar Link	pending
nrom_ex107img121.jpg	Edgar Link	pending
nrom_ex107img122.jpg	Edgar Link	pending
nrom_ex107img123.jpg	Edgar Link	pending
nrom_ex107img124.jpg	Edgar Link	pending
nrom_ex107img125.jpg	Edgar Link	pending
nrom_ex107img126.jpg	Edgar Link	pending
nrom_ex107img127.jpg	Edgar Link	pending
nrom_ex107img128.jpg	Edgar Link	pending
nrom_ex107img129.jpg	Edgar Link	pending
nrom_ex107img13.jpg	Edgar Link	pending
nrom_ex107img130.jpg	Edgar Link	pending
nrom_ex107img131.jpg	Edgar Link	pending
nrom_ex107img132.jpg	Edgar Link	pending
nrom_ex107img14.jpg	Edgar Link	pending
nrom_ex107img15.jpg	Edgar Link	pending
nrom_ex107img16.jpg	Edgar Link	pending
nrom_ex107img17.jpg	Edgar Link	pending
nrom_ex107img18.jpg	Edgar Link	pending
nrom-20230331_cal.xml	Edgar Link	unprocessable
nrom-20230331_lab.xml	Edgar Link	unprocessable
nrom-20230331_pre.xml	Edgar Link	unprocessable
nrom_10q_htm.xml	Edgar Link	completed
nrom_ex107img19.jpg	Edgar Link	pending
nrom_ex107img2.jpg	Edgar Link	pending
nrom_ex107img20.jpg	Edgar Link	pending
nrom_ex107img21.jpg	Edgar Link	pending
nrom_ex107img22.jpg	Edgar Link	pending
nrom_ex107img23.jpg	Edgar Link	pending
nrom_ex107img24.jpg	Edgar Link	pending
nrom_ex107img25.jpg	Edgar Link	pending
nrom_ex107img26.jpg	Edgar Link	pending
nrom_ex107img27.jpg	Edgar Link	pending
nrom_ex107img28.jpg	Edgar Link	pending
nrom_ex107img29.jpg	Edgar Link	pending
nrom_ex107img3.jpg	Edgar Link	pending
nrom_ex107img30.jpg	Edgar Link	pending
nrom_ex107img31.jpg	Edgar Link	pending
nrom_ex107img32.jpg	Edgar Link	pending
nrom_ex107img33.jpg	Edgar Link	pending
nrom_ex107img34.jpg	Edgar Link	pending
nrom_ex107img35.jpg	Edgar Link	pending
nrom_ex107img36.jpg	Edgar Link	pending
nrom_ex107img37.jpg	Edgar Link	pending
nrom_ex107img38.jpg	Edgar Link	pending
nrom_ex107img39.jpg	Edgar Link	pending
nrom_ex107img4.jpg	Edgar Link	pending
nrom_ex107img40.jpg	Edgar Link	pending
nrom_ex107img41.jpg	Edgar Link	pending
nrom_ex107img42.jpg	Edgar Link	pending
nrom_ex107img43.jpg	Edgar Link	pending
nrom_ex107img44.jpg	Edgar Link	pending
nrom_ex107img45.jpg	Edgar Link	pending
nrom_ex107img46.jpg	Edgar Link	pending
nrom_ex107img47.jpg	Edgar Link	pending
nrom_ex107img48.jpg	Edgar Link	pending
nrom_ex107img49.jpg	Edgar Link	pending
nrom_ex107img5.jpg	Edgar Link	pending
nrom_ex107img50.jpg	Edgar Link	pending
nrom_ex107img51.jpg	Edgar Link	pending
nrom_ex107img52.jpg	Edgar Link	pending
nrom_ex107img53.jpg	Edgar Link	pending
nrom_ex107img54.jpg	Edgar Link	pending
nrom_ex107img55.jpg	Edgar Link	pending
nrom_ex107img56.jpg	Edgar Link	pending
nrom_ex107img57.jpg	Edgar Link	pending
nrom_ex107img58.jpg	Edgar Link	pending
nrom_ex107img59.jpg	Edgar Link	pending
nrom_ex107img6.jpg	Edgar Link	pending
nrom_ex107img60.jpg	Edgar Link	pending
nrom_ex107img61.jpg	Edgar Link	pending
nrom_ex107img62.jpg	Edgar Link	pending
nrom_ex107img63.jpg	Edgar Link	pending
nrom_ex107img64.jpg	Edgar Link	pending
nrom_ex107img65.jpg	Edgar Link	pending
nrom_ex107img66.jpg	Edgar Link	pending
nrom_ex107img67.jpg	Edgar Link	pending
nrom_ex107img68.jpg	Edgar Link	pending
nrom_ex107img69.jpg	Edgar Link	pending
nrom_ex107img7.jpg	Edgar Link	pending
nrom_ex107img70.jpg	Edgar Link	pending
nrom_ex107img71.jpg	Edgar Link	pending
nrom_ex107img72.jpg	Edgar Link	pending
nrom_ex107img73.jpg	Edgar Link	pending
nrom_ex107img74.jpg	Edgar Link	pending
nrom_ex107img75.jpg	Edgar Link	pending
nrom_ex107img76.jpg	Edgar Link	pending
nrom_ex107img77.jpg	Edgar Link	pending
nrom_ex107img78.jpg	Edgar Link	pending
nrom_ex107img79.jpg	Edgar Link	pending
nrom_ex107img8.jpg	Edgar Link	pending
nrom_ex107img80.jpg	Edgar Link	pending
nrom_ex107img81.jpg	Edgar Link	pending
nrom_ex107img82.jpg	Edgar Link	pending
nrom_ex107img83.jpg	Edgar Link	pending
nrom_ex107img84.jpg	Edgar Link	pending
nrom_ex107img85.jpg	Edgar Link	pending
nrom_ex107img86.jpg	Edgar Link	pending
nrom_ex107img87.jpg	Edgar Link	pending
nrom_ex107img88.jpg	Edgar Link	pending
nrom_ex107img89.jpg	Edgar Link	pending
nrom_ex107img9.jpg	Edgar Link	pending
nrom_ex107img90.jpg	Edgar Link	pending
nrom_ex107img91.jpg	Edgar Link	pending
nrom_ex107img92.jpg	Edgar Link	pending
nrom_ex107img93.jpg	Edgar Link	pending
nrom_ex107img94.jpg	Edgar Link	pending
nrom_ex107img95.jpg	Edgar Link	pending
nrom_ex107img96.jpg	Edgar Link	pending
nrom_ex107img97.jpg	Edgar Link	pending
nrom_ex107img98.jpg	Edgar Link	pending
nrom_ex107img99.jpg	Edgar Link	pending
nrom_ex311.htm	Edgar Link	pending
nrom_ex312.htm	Edgar Link	pending
nrom_ex321.htm	Edgar Link	pending
nrom_ex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NROM
NOBLE ROMANS INC Stock $nrom

2023 Q2 Form 10-Q Financial Statement

#000165495423006093 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NROM NOBLE ROMANS INC Stock $nrom

2023 Q2 Form 10-Q Financial Statement

#000165495423006093 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NROM
NOBLE ROMANS INC Stock $nrom